{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:20:26Z","timestamp":1792092026351,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T00:00:00Z","timestamp":1480118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81171182"],"award-info":[{"award-number":["81171182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81671235"],"award-info":[{"award-number":["81671235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12035-016-0283-7","type":"journal-article","created":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T05:42:29Z","timestamp":1480138949000},"page":"8110-8116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases"],"prefix":"10.1007","volume":"54","author":[{"given":"Xinbo","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunqian","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,26]]},"reference":[{"issue":"2","key":"283_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ajhg.2008.07.004","volume":"83","author":"HR Elliott","year":"2008","unstructured":"Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83(2):254\u2013260. doi:\n10.1016\/j.ajhg.2008.07.004","journal-title":"Am J Hum Genet"},{"key":"283_CR2","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/brain\/awg170","volume":"126","author":"D Skladal","year":"2003","unstructured":"Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126:1905\u20131912. doi:\n10.1093\/brain\/awg170","journal-title":"Brain"},{"issue":"5","key":"283_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.24362","volume":"77","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, Feeney C, Horvath R et al (2015) Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol 77(5):753\u2013759. doi:\n10.1002\/ana.24362","journal-title":"Ann Neurol"},{"issue":"1","key":"283_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2005.12.001","volume":"3","author":"JA Smeitink","year":"2006","unstructured":"Smeitink JA, Zeviani M, Turnbull DM, Jacobs HT (2006) Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab 3(1):9\u201313. doi:\n10.1016\/j.cmet.2005.12.001","journal-title":"Cell Metab"},{"issue":"5","key":"283_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00415-009-5028-3","volume":"256","author":"S Di Donato","year":"2009","unstructured":"Di Donato S (2009) Multisystem manifestations of mitochondrial disorders. J Neurol 256(5):693\u2013710. doi:\n10.1007\/s00415-009-5028-3","journal-title":"J Neurol"},{"issue":"12","key":"283_CR6","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/j.1468-1331.2009.02811.x","volume":"16","author":"J Finsterer","year":"2009","unstructured":"Finsterer J, Harbo HF, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A et al (2009) EFNS guidelines on the molecular diagnosis of mitochondrial disorders. Eur J Neurol 16(12):1255\u20131264. doi:\n10.1111\/j.1468-1331.2009.02811.x","journal-title":"Eur J Neurol"},{"issue":"4","key":"283_CR7","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1073\/pnas.0906039107","volume":"107","author":"O Shaham","year":"2010","unstructured":"Shaham O, Slate NG, Goldberger O, Xu QW, Ramanathan A, Souza AL, Clish CB, Sims KB et al (2010) A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc Natl Acad Sci U S A 107(4):1571\u20131575. doi:\n10.1073\/pnas.0906039107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"283_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10545-010-9222-3","volume":"34","author":"A Suomalainen","year":"2011","unstructured":"Suomalainen A (2011) Biomarkers for mitochondrial respiratory chain disorders. J Inherit Metab Dis 34(2):277\u2013282. doi:\n10.1007\/s10545-010-9222-3","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"283_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/s1474-4422(11)70155-2","volume":"10","author":"A Suomalainen","year":"2011","unstructured":"Suomalainen A, Elo JM, Pietilainen KH, Hakonen AH, Sevastianova K, Korpela M, Isohanni P, Marjavaara SK et al (2011) FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol 10(9):806\u2013818. doi:\n10.1016\/s1474-4422(11)70155-2","journal-title":"Lancet Neurol"},{"issue":"21","key":"283_CR10","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1212\/01.wnl.0000436068.43384.ef","volume":"81","author":"RL Davis","year":"2013","unstructured":"Davis RL, Liang C, Edema-Hildebrand F, Riley C, Needham M, Sue CM (2013) Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology 81(21):1819\u20131826. doi:\n10.1212\/01.wnl.0000436068.43384.ef","journal-title":"Neurology"},{"issue":"3","key":"283_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/jcp.22196","volume":"224","author":"M Mimeault","year":"2010","unstructured":"Mimeault M, Batra SK (2010) Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer. J Cell Physiol 224(3):626\u2013635. doi:\n10.1002\/jcp.22196","journal-title":"J Cell Physiol"},{"issue":"4","key":"283_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cytogfr.2013.05.003","volume":"24","author":"K Unsicker","year":"2013","unstructured":"Unsicker K, Spittau B, Krieglstein K (2013) The multiple facets of the TGF-beta family cytokine growth\/differentiation factor-15\/macrophage inhibitory cytokine-1. Cytokine Growth Factor Rev 24(4):373\u2013384. doi:\n10.1016\/j.cytogfr.2013.05.003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"283_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ndt\/gfr575","volume":"27","author":"SN Breit","year":"2012","unstructured":"Breit SN, Carrero JJ, Tsai VWW, Yagoutifam N, Luo W, Kuffner T, Bauskin AR, Wu LY et al (2012) Macrophage inhibitory cytokine-1 (MIC-1\/GDF15) and mortality in end-stage renal disease. Nephrology Dialysis Transplantation 27(1):70\u201375. doi:\n10.1093\/ndt\/gfr575","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"283_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejim.2011.08.022","volume":"23","author":"S Montoro-Garcia","year":"2012","unstructured":"Montoro-Garcia S, Hernandez-Romero D, Jover E, Garcia-Honrubia A, Vilchez JA, Casas T, Martinez P, Climent V et al (2012) Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy. European Journal of Internal Medicine 23(2):169\u2013174. doi:\n10.1016\/j.ejim.2011.08.022","journal-title":"European Journal of Internal Medicine"},{"issue":"4","key":"283_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/cc12765","volume":"17","author":"T Kempf","year":"2013","unstructured":"Kempf T, Wollert KC (2013) Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndrome. Crit Care 17(4):2. doi:\n10.1186\/cc12765","journal-title":"Crit Care"},{"issue":"3","key":"283_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cjca.2013.12.010","volume":"30","author":"Y Izumiya","year":"2014","unstructured":"Izumiya Y, Hanatani S, Kimura Y, Takashio S, Yamamoto E, Kusaka H, Tokitsu T, Rokutanda T et al (2014) Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction. Can J Cardiol 30(3):338\u2013344. doi:\n10.1016\/j.cjca.2013.12.010","journal-title":"Can J Cardiol"},{"issue":"2","key":"283_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/igc.0000000000000037","volume":"24","author":"J Trovik","year":"2014","unstructured":"Trovik J, Salvesen HB, Cuppens T, Amant F, Staff AC (2014) Growth differentiation factor-15 as biomarker in uterine sarcomas. Int J Gynecol Cancer 24(2):252\u2013259. doi:\n10.1097\/igc.0000000000000037","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"283_CR18","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/annonc\/mdu120","volume":"25","author":"CZ Yang","year":"2014","unstructured":"Yang CZ, Ma J, Zhu DW, Liu Y, Montgomery B, Wang LZ, Li J, Zhang ZY et al (2014) GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma. Ann Oncol 25(6):1215\u20131222. doi:\n10.1093\/annonc\/mdu120","journal-title":"Ann Oncol"},{"key":"283_CR19","doi-asserted-by":"publisher","unstructured":"Koene S, de Laat P, van Tienoven DH, Weijers G, Vriens D, Sweep FC, Timmermans J, Kapusta L, Janssen MC, Smeitink JA (2015) Serum GDF15 levels correlate to mitochondrial disease severity and myocardial strain, but not to disease progression in adult m.3243A>G carriers. JIMD reports. doi:\n10.1007\/8904_2015_436","DOI":"10.1007\/8904_2015_436"},{"issue":"5","key":"283_CR20","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/ana.24506","volume":"78","author":"S Yatsuga","year":"2015","unstructured":"Yatsuga S, Fujita Y, Ishii A, Fukumoto Y, Arahata H, Kakuma T, Kojima T, Ito M et al (2015) Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Ann Neurol 78(5):814\u2013823. doi:\n10.1002\/ana.24506","journal-title":"Ann Neurol"},{"issue":"12","key":"283_CR21","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1212\/01.wnl.0000219759.72195.41","volume":"66","author":"AM Schaefer","year":"2006","unstructured":"Schaefer AM, Phoenix C, Elson JL, McFarland R, Chinnery PF, Turnbull DM (2006) Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology 66(12):1932\u20131934. doi:\n10.1212\/01.wnl.0000219759.72195.41","journal-title":"Neurology"},{"key":"283_CR22","doi-asserted-by":"publisher","DOI":"10.3109\/00207454.2015.1034801","author":"F Liu","year":"2015","unstructured":"Liu F, Lou J, Zhao D, Li W, Zhao Y, Sun X, Yan C (2015) Dysferlinopathy: mitochondrial abnormalities in human skeletal muscle. The International Journal of Neuroscience. doi:\n10.3109\/00207454.2015.1034801","journal-title":"The International Journal of Neuroscience"},{"issue":"Suppl 1","key":"283_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ggi.12724","volume":"16","author":"Y Fujita","year":"2016","unstructured":"Fujita Y, Taniguchi Y, Shinkai S, Tanaka M, Ito M (2016) Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders. Geriatrics & Gerontology International 16(Suppl 1):17\u201329. doi:\n10.1111\/ggi.12724","journal-title":"Geriatrics & Gerontology International"},{"issue":"4","key":"283_CR24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.bbrc.2007.01.089","volume":"354","author":"M Osada","year":"2007","unstructured":"Osada M, Park HL, Park MJ, Liu JW, Wu GJ, Trink B, Sidransky D (2007) A p53-type response element in the GDF15 promoter confers high specificity for p53 activation. Biochem Biophys Res Commun 354(4):913\u2013918. doi:\n10.1016\/j.bbrc.2007.01.089","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"283_CR25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.tiv.2015.05.008","volume":"29","author":"KK Tiwari","year":"2015","unstructured":"Tiwari KK, Moorthy B, Lingappan K (2015) Role of GDF15 (growth and differentiation factor 15) in pulmonary oxygen toxicity. Toxicology in Vitro an International Journal Published in Association with BIBRA 29(7):1369\u20131376. doi:\n10.1016\/j.tiv.2015.05.008","journal-title":"Toxicology in Vitro an International Journal Published in Association with BIBRA"},{"key":"283_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2164-15-91","volume":"15","author":"SG Kalko","year":"2014","unstructured":"Kalko SG, Paco S, Jou C, Rodriguez MA, Meznaric M, Rogac M, Jekovec-Vrhovsek M, Sciacco M et al (2014) Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies. BMC Genomics 15:91. doi:\n10.1186\/1471-2164-15-91","journal-title":"BMC Genomics"},{"issue":"26","key":"283_CR27","doi-asserted-by":"publisher","first-page":"20127","DOI":"10.1074\/jbc.M909580199","volume":"275","author":"PX Li","year":"2000","unstructured":"Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C, Austin RC, Klamut HJ (2000) Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 275(26):20127\u201320135. doi:\n10.1074\/jbc.M909580199","journal-title":"J Biol Chem"},{"key":"283_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.freeradbiomed.2015.03.020","volume":"84","author":"K Ji","year":"2015","unstructured":"Ji K, Zheng J, Lv J, Xu J, Ji X, Luo YB, Li W, Zhao Y et al (2015) Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1alpha pathway. Free Radic Biol Med 84:161\u2013170. doi:\n10.1016\/j.freeradbiomed.2015.03.020","journal-title":"Free Radic Biol Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0283-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0283-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0283-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T07:42:26Z","timestamp":1510558946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0283-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,26]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0283-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,26]]}}}